Chance of ESBL contamination via livestock farming is small ESBL is an enzyme, produced by certain bacteria, which makes these bacteria resistant to antibiotics.
RIVM publications score above average worldwide A new bibliometric analysis method of the University of Leiden shows that the publications of the Strategic Programme of RIVM (SPR) score well worldwide.
New test has no added value in Lyme disease of the central nervous system Active Lyme disease of the central nervous system cannot be detected with an ELISpot test.
Mental care still the most expensive of all In 2011, 19.6 billion euros was spent on the treatment of mental disorders. This amounted to 22% of the total expenditure on health and welfare during that year.
Risks of eHealth technology RIVM and Nictiz have made an overview of the risks that eHealth applications may entail and how these risks can be controlled.
Key organisations unite to improve benefit and risk assessments of vaccines Leading organisations have joined forces to launch a unique project that will pave the way for a pan-European framework for rapidly assessing and communicating the benefits and risks of vaccines.
Human and veterinary health sectors join forces for responsible use of antibiotics. Bacteria that are resistant to almost all antibiotics continue to spread across Europe. This was revealed by new figures from the European Centre for Disease Prevention and Control (ECDC).
In The Spotlight: Young Researchers RIVM 'Young Researchers' present their PhD research in 4 short films which were made especially to highlight and explain their scientific research.
Knowledge Centre Healthy Urban Living; for better quality of life in cities The Knowledge Centre on Healthy Urban Living starts on 12 November 2013.